ABVC BioPharma, Inc. Debt Instrument Issued Principal
ABVC BioPharma, Inc. (ECOC) reported Debt Instrument Issued Principal of $559.01 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Financial Services
us-gaap:DebtInstrumentIssuedPrincipal · last filed 2026-08-12
- ABVC BioPharma, Inc. debt instrument issued principal for the quarter ending 2026-06-30 was $0.00.
- ABVC BioPharma, Inc. debt instrument issued principal for the quarter ending 2026-03-31 was $559.01K, a 75.27% decline year-over-year.
- ABVC BioPharma, Inc. debt instrument issued principal for the quarter ending 2025-06-30 was -$1.19M, a 137.60% decline year-over-year.
- ABVC BioPharma, Inc. debt instrument issued principal for the quarter ending 2025-03-31 was $2.26M.
- ABVC BioPharma, Inc. debt instrument issued principal for fiscal 2023 was $4.90M.
USD
| Period end | Debt Instrument Issued Principal 3 month | Debt Instrument Issued Principal 6 month | Debt Instrument Issued Principal 9 month | Debt Instrument Issued Principal 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $559.01K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $559.01K 10-Q · filed 2026-05-18 | |||
| 2025-12-31 | $559.01K 10-Q · filed 2026-08-12 | |||
| 2025-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.07M 10-Q · filed 2025-08-13 | $161.72K derived: sum of 3 quarters · filed 2026-03-03 | |
| 2025-03-31 | $2.26M 10-Q · filed 2025-04-30 | $1.35M derived: sum of 2 quarters · filed 2026-03-03 | ||
| 2024-12-31 | -$907.29K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2026-03-03 | $2.26M 10-Q/A · filed 2026-03-03 | ||
| 2024-09-30 | $3.17M 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $3.17M 10-Q · filed 2024-08-14 | |||
| 2023-12-31 | $4.90M 10-K · filed 2025-04-15 |
TWD
| Period end | Debt Instrument Issued Principal 3 month | Debt Instrument Issued Principal 6 month | Debt Instrument Issued Principal 9 month |
|---|---|---|---|
| 2025-09-30 | 39.04M TWD derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | 77.78M TWD 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | 38.74M TWD 10-Q · filed 2025-08-13 |